Rising Diagnosis of Viral Meningitis Is Often Delayed
By LabMedica International staff writers Posted on 10 Jul 2018 |

Image: A stained cerebrospinal fluid preparation from a case of acute bacterial (pneumococcal) meningitis. There are numerous neutrophils and bacteria (Photo courtesy of Dr. Edmund S. Cibas, MD).
As the incidence of bacterial meningitis decreases, the proportion of meningitis cases caused by viruses is increasing and the use of molecular diagnostics has also led to increased recognition of neurological viral infections.
Identification of the cause of meningitis is important to improve clinical care, including reducing unnecessary use of antibiotics and antivirals. Patients with suspected viral meningitis are often treated with antibiotics while a diagnosis of bacterial meningitis is excluded, which results in patients receiving long courses of antibiotics and can extend their hospital stay.
A large team of scientists working with the University of Liverpool (Liverpool, UK) carried out a multicenter prospective observational cohort study of adults with suspected meningitis at 42 hospitals across England. The investigators enrolled 1,126 patients were enrolled between September 30, 2011, and September 30, 2014. There were 638 (57%) patients who had meningitis: 231 (36%) cases were viral, 99 (16%) were bacterial and 267 (42%) had an unknown cause. 41 (6%) cases had other causes.
The team identified cerebrospinal fluid (CSF) samples with a leucocyte count of more than 4 × 106 cells/L from laboratory records and classified them according to pathogen identified (or unknown if none was found). All CSF samples were examined by microscopy and culture. CSF polymerase chain reaction (PCR) was done in the admitting hospitals, regional diagnostic centers, or the University of Liverpool, to test for herpes simplex virus types 1 and 2, varicella zoster virus, and enteroviruses, as well as Streptococcus pneumoniae and Neisseria meningitidis, following national recommendations. They applied a proportional inflation, based on the total number of cases (those recruited and those missed) divided by the actual number recruited into the northwest sites in the prospective study, to the initial estimated northwest incidence data.
The team found that found that diagnosis of meningitis was often delayed due to unnecessary brain scans being performed before lumbar puncture, which is the essential investigation to determine the cause of the illness. The majority of patients (81%) had a brain scan and 70% of those took place before lumbar puncture, otherwise known as a spinal tap. Overall, the specific virus or bacteria causing the illness was not identified for 43% of patients.
The authors concluded that their findings demonstrated that viruses are the predominant cause of adult meningitis in the UK, with enteroviruses and herpesviruses responsible for the majority of cases for which a cause is found. Michael Griffiths, BMedSci, BMBS, DPhil, a senior clinical lecturer and a co-author of the study, said, “Diagnosing a specific cause of meningitis quickly is key to getting patients on the right antibiotics, if needed, or avoiding unnecessary antibiotics in those with viral meningitis. Once viral meningitis has been diagnosed, efforts should focus on treatment of the symptoms and expediting discharge from hospital, which would be less distressing for patients and ease pressures on the NHS. The study was published on June 29, 2018, in the journal The Lancet Infectious Diseases.
Related Links:
University of Liverpool
Identification of the cause of meningitis is important to improve clinical care, including reducing unnecessary use of antibiotics and antivirals. Patients with suspected viral meningitis are often treated with antibiotics while a diagnosis of bacterial meningitis is excluded, which results in patients receiving long courses of antibiotics and can extend their hospital stay.
A large team of scientists working with the University of Liverpool (Liverpool, UK) carried out a multicenter prospective observational cohort study of adults with suspected meningitis at 42 hospitals across England. The investigators enrolled 1,126 patients were enrolled between September 30, 2011, and September 30, 2014. There were 638 (57%) patients who had meningitis: 231 (36%) cases were viral, 99 (16%) were bacterial and 267 (42%) had an unknown cause. 41 (6%) cases had other causes.
The team identified cerebrospinal fluid (CSF) samples with a leucocyte count of more than 4 × 106 cells/L from laboratory records and classified them according to pathogen identified (or unknown if none was found). All CSF samples were examined by microscopy and culture. CSF polymerase chain reaction (PCR) was done in the admitting hospitals, regional diagnostic centers, or the University of Liverpool, to test for herpes simplex virus types 1 and 2, varicella zoster virus, and enteroviruses, as well as Streptococcus pneumoniae and Neisseria meningitidis, following national recommendations. They applied a proportional inflation, based on the total number of cases (those recruited and those missed) divided by the actual number recruited into the northwest sites in the prospective study, to the initial estimated northwest incidence data.
The team found that found that diagnosis of meningitis was often delayed due to unnecessary brain scans being performed before lumbar puncture, which is the essential investigation to determine the cause of the illness. The majority of patients (81%) had a brain scan and 70% of those took place before lumbar puncture, otherwise known as a spinal tap. Overall, the specific virus or bacteria causing the illness was not identified for 43% of patients.
The authors concluded that their findings demonstrated that viruses are the predominant cause of adult meningitis in the UK, with enteroviruses and herpesviruses responsible for the majority of cases for which a cause is found. Michael Griffiths, BMedSci, BMBS, DPhil, a senior clinical lecturer and a co-author of the study, said, “Diagnosing a specific cause of meningitis quickly is key to getting patients on the right antibiotics, if needed, or avoiding unnecessary antibiotics in those with viral meningitis. Once viral meningitis has been diagnosed, efforts should focus on treatment of the symptoms and expediting discharge from hospital, which would be less distressing for patients and ease pressures on the NHS. The study was published on June 29, 2018, in the journal The Lancet Infectious Diseases.
Related Links:
University of Liverpool
Latest Microbiology News
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
Troponin is a protein found in heart muscle cells that is released into the bloodstream when the heart is damaged. High-sensitivity troponin blood tests are commonly used in hospitals to diagnose heart... Read more
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more